Device
Endeavor Resolute Stent
Endeavor Resolute Stent is a medical device with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_4
2
67%
Phase Distribution
0
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution2 total trials
Phase 4Post-market surveillance
2(100.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(2)
Other(1)
Detailed Status
Completed2
unknown1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 42 (100.0%)
Trials by Status
unknown133%
completed267%
Recent Activity
0 active trials
Showing 3 of 3
completed
Assessment of Clinical Performance and Costs of the Endeavor Resolute Stent "in Real Life" in Spain.
NCT00850213
completedphase_4
Comparison of Zotarolimus-Eluting Stent vs Sirolimus-Eluting Stent for Diabetic Patients
NCT01186107
unknownphase_4
Zotarolimus and Everolimus-Eluting Stents ProsPectively Compared in Real World
NCT00768846
Clinical Trials (3)
Showing 3 of 3 trials
NCT00850213
Assessment of Clinical Performance and Costs of the Endeavor Resolute Stent "in Real Life" in Spain.
NCT01186107Phase 4
Comparison of Zotarolimus-Eluting Stent vs Sirolimus-Eluting Stent for Diabetic Patients
NCT00768846Phase 4
Zotarolimus and Everolimus-Eluting Stents ProsPectively Compared in Real World
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3